Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
No sooner had John F. Kennedy’s granddaughter died of leukemia at age 35, than President Trump cast shade at her bereaved family via Truth Social. According to the Lehigh County coroner, a man has ...